# OnCo record nct04910022 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04910022/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04910022", "NCT04910022" ;
  schema:name "Ph I/II Study of NMS-03305293+TMZ in Adult Patients With Recurrent Glioblastoma"@en ;
  schema:description "This study tests a PARP inhibitor; the registry reports that it is active not recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04910022/> ;
  schema:dateModified "2026-10-06"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04910022> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2021-12-01" ;
  onco:cancers <https://onco.cc/cancers/glioblastoma/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/parp/> ;
  onco:drugs <https://onco.cc/drugs/temozolomide/>, <https://onco.cc/drugs/nms-03305293/> ;
  onco:companies <https://onco.cc/companies/nerviano-medical-sciences/> .